Results 1 - 6 of 6
The drugmaker and Genzyme want to extend voting on their proposed merger.
Bioenvision Shareholder Battle
A vote on a proposed acquisition approaches.
More Than Momentum: Stocks Rising for a Reason
Sorting a real growth story from a flash in the pan.
These low-rated picks show that a stock doesn't have to be loved to outperform.
Genzyme acquires one of its partners.
Who's fallen hardest? Who can bounce highest?
Results 1 - 6 of 6
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK